Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. The Lancet. 2018;391(10130):1622–36. https://doi.org/10.1016/S0140-6736(18)30481-1.
Ascherio A, Munger K. Epidemiology of multiple sclerosis: from risk factors to prevention—an update. Semin Neurol. 2016;36(02):103–14. https://doi.org/10.1055/s-0036-1579693.
Howard J, Trevick S, Younger DS. Epidemiology of multiple sclerosis. Neurol Clin. 2016;34(4):919–39. https://doi.org/10.1016/j.ncl.2016.06.016.
Walton C, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler J. 2020;26(14):1816–21. https://doi.org/10.1177/1352458520970841.
Winquist RJ, Kwong A, Ramachandran R, Jain J. The complex etiology of multiple sclerosis. Biochem Pharmacol. 2007;74(9):1321–9. https://doi.org/10.1016/j.bcp.2007.04.026.
Article CAS PubMed Google Scholar
Sintzel MB, Rametta M, Reder AT. Vitamin D and multiple sclerosis: a comprehensive review. Neurol Ther. 2018;7(1):59–85. https://doi.org/10.1007/s40120-017-0086-4.
Soldan SS, Lieberman PM. Epstein–Barr virus and multiple sclerosis. Nat Rev Microbiol. 2023;21(1):51–64. https://doi.org/10.1038/s41579-022-00770-5.
Article CAS PubMed Google Scholar
Cappelletti C, et al. Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls. Clin Proteomics. 2022;19(1):23. https://doi.org/10.1186/s12014-022-09361-1.
Article CAS PubMed PubMed Central Google Scholar
Chitnis T. The role of CD4 T cells in the pathogenesis of multiple sclerosis. Int Rev Neurobiol. 2007;79:43–72. https://doi.org/10.1016/S0074-7742(07)79003-7.
Mey GM, Mahajan KR, DeSilva TM. ‘Neurodegeneration in multiple sclerosis. WIREs Mech Dis. 2023;15:1. https://doi.org/10.1002/wsbm.1583.
Racke M. Immunopathogenesis of multiple sclerosis. Ann Indian Acad Neurol. 2009;12(4):215. https://doi.org/10.4103/0972-2327.58274.
Article PubMed PubMed Central Google Scholar
Dhanapalaratnam R, Markoulli M, Krishnan AV. Disorders of vision in multiple sclerosis. Clin Exp Optom. 2022;105(1):3–12. https://doi.org/10.1080/08164622.2021.1947745.
Ghosh R, Roy D, Dubey S, Das S, Benito-León J. Movement disorders in multiple sclerosis: an update. Tremor Other Hyperkinetic Movements. 2022;12(1):14. https://doi.org/10.5334/tohm.671.
Article PubMed PubMed Central Google Scholar
Lisak M, Špiljak B, Pašić H, Trkanjec Z. Cognitive aspects in multiple sclerosis. Psychiatr Danub. 2021;33(Suppl 13):177–82.
Potulska-Chromik A, et al. Original article clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature. Folia Neuropathol. 2014;1:92–100. https://doi.org/10.5114/fn.2014.41747.
Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun. 2008;31(3):252–6. https://doi.org/10.1016/j.jaut.2008.04.017.
Article CAS PubMed PubMed Central Google Scholar
Høglund RA. Multiple sclerosis and the role of immune cells. World J Exp Med. 2014;4(3):27. https://doi.org/10.5493/wjem.v4.i3.27.
Article PubMed PubMed Central Google Scholar
Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KHG. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010;162(1):1–11. https://doi.org/10.1111/j.1365-2249.2010.04143.x.
Article CAS PubMed PubMed Central Google Scholar
Yuan X, et al. Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes. Nat Commun. 2022;13(1):6356. https://doi.org/10.1038/s41467-022-33656-4.
Article ADS CAS PubMed PubMed Central Google Scholar
Xin X, Wang Q, Qing J, et al. Th17 cells in primary Sjögren's syndrome negatively correlate with increased Roseburia and Coprococcus. Front Immunol. 2022;13:974648. https://doi.org/10.3389/fimmu.2022.974648.
Freedman SN, Shahi SK, Mangalam AK. The “gut feeling”: breaking down the role of gut microbiome in multiple sclerosis. Neurotherapeutics. 2018;15(1):109–25. https://doi.org/10.1007/s13311-017-0588-x.
Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823–36. https://doi.org/10.1042/BCJ20160510.
Article CAS PubMed Google Scholar
Yatsunenko T, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–7. https://doi.org/10.1038/nature11053.
Article ADS CAS PubMed PubMed Central Google Scholar
Senn V, Bassler D, Choudhury R, et al. Microbial colonization from the fetus to early childhood-a comprehensive review [published correction appears in Front Cell Infect Microbiol. 2021 Jun 30;11:715671]. Front Cell Infect Microbiol. 2020;10:573735. https://doi.org/10.3389/fcimb.2020.573735.
Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76(3):473–93. https://doi.org/10.1007/s00018-018-2943-4.
Article CAS PubMed Google Scholar
Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–41. https://doi.org/10.1016/j.cell.2014.03.011.
Article CAS PubMed PubMed Central Google Scholar
Mörbe UM, et al. Human gut-associated lymphoid tissues (GALT); diversity, structure, and function. Mucosal Immunol. 2021;14(4):793–802. https://doi.org/10.1038/s41385-021-00389-4.
Article CAS PubMed Google Scholar
Kasarello K, Cudnoch-Jedrzejewska A, Czarzasta K. Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front Microbiol. 2023;14:1118529. https://doi.org/10.3389/fmicb.2023.1118529.
Kim M, Kim CH. Regulation of humoral immunity by gut microbial products. Gut Microbes. 2017;8(4):392–9. https://doi.org/10.1080/19490976.2017.1299311.
Article CAS PubMed PubMed Central Google Scholar
Linares DM, Ross P, Stanton C. Beneficial microbes: the pharmacy in the gut. Bioengineered. 2016;7(1):11–20. https://doi.org/10.1080/21655979.2015.1126015.
Article CAS PubMed Google Scholar
Macpherson AJ, Uhr T. (2004) ‘Induction of protective iga by intestinal dendritic cells carrying commensal bacteria.’ Science. 1979;303(5664):1662–5. https://doi.org/10.1126/science.1091334.
Article ADS CAS Google Scholar
Sutherland DB, Fagarasan S. IgA synthesis: a form of functional immune adaptation extending beyond gut. Curr Opin Immunol. 2012;24(3):261–8. https://doi.org/10.1016/j.coi.2012.03.005.
Article CAS PubMed Google Scholar
Rinninella E, et al. ‘What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases.’ Microorganisms. 2019;7(1):14. https://doi.org/10.3390/microorganisms7010014.
Article CAS PubMed PubMed Central Google Scholar
Cignarella F, et al. Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota. Cell Metab. 2018;27(6):1222-1235.e6. https://doi.org/10.1016/j.cmet.2018.05.006.
Article CAS PubMed PubMed Central Google Scholar
DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016;22(5):1137–50. https://doi.org/10.1097/MIB.0000000000000750.
Wexler HM. Bacteroides : the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007;20(4):593–621. https://doi.org/10.1128/CMR.00008-07.
Article CAS PubMed PubMed Central Google Scholar
Zhang Y-J, Li S, Gan R-Y, Zhou T, Xu D-P, Li H-B. Impacts of gut bacteria on human health and diseases. Int J Mol Sci. 2015;16(12):7493–519. https://doi.org/10.3390/ijms16047493.
Article CAS PubMed PubMed Central Google Scholar
Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26:0. https://doi.org/10.3402/mehd.v26.26191.
Vacaras V, et al. The ro
留言 (0)